Keeping Track: Psoriasis Gets New Topical In Arcutis’ Zoryve; Cidara Submits IV Antifungal

 
• By Bridget Silverman
Keeping Track Feature image
The US has seen a trend toward topical dermatology approvals.

More from US FDA Performance Tracker

More from Regulatory Trackers